Sheza Malik
Appearances
- DateMay 21, 2024Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are integral in managing type 2 diabetes. However, their long-term impact on gastrointestinal and hepatobiliary health remains uncertain…
Presenter
Speakers
- DateMay 18, 2024Background: Primary Sclerosing Cholangitis (PSC), a chronic liver disease, is often intertwined with Inflammatory Bowel Disease (IBD), presenting a complex clinical scenario. The coexistence of IBD-PSC complicates disease management and progression, potentially exacerbating outcomes…
Presenter
Speakers
Rochester Regional Health - DateMay 18, 2024BACKGROUND & AIMS: Endoscopy stricturotomy has gathered attention in the treatment of strictures in patients with inflammatory bowel disease (IBD) and seems to be a promising novel approach…
Presenter
Speakers
Saint Peters University HospitalUniversity of Utah School of Medicine